Globoid cell leukodystrophy (GLD), or Krabbe disease, is a rare and often fatal
demyelinating disease caused by mutations in the galactocerebrosidase
(galc) gene that result in accumulation of galactosylsphingosine
(‘psychosine’). We recently reported that the extracellular matrix (ECM)
protease, matrix metalloproteinase (MMP)-3, is elevated in GLD and that it regulates
psychosine-induced microglial activation. Here, we examined central nervous system ECM
component expression in human GLD patients and in the twitcher mouse model of GLD using
immunohistochemistry. The influence of ECM proteins on primary murine microglial responses
to psychosine was evaluated using ECM proteins as substrates and analyzed by quantitative
real-time polymerase chain reaction (qRT-PCR), immunocytochemistry, and ELISA. Functional
analysis of microglial cytotoxicity was performed on oligodendrocytes in co-culture and
cell death was measured by lactose dehydrogenase assay. Tenascin-C (TnC) was expressed at
higher levels in human GLD and in twitcher mice vs. controls. Microglial responses to
psychosine were enhanced by TnC, as determined by an increase in
‘globoid-like’ cell formation, MMP-3 mRNA expression and higher toxicity
toward oligodendrocytes in culture. These findings were consistent with a shift toward the
M1 microglial phenotype in TnC grown microglia. Thus, elevated TnC expression in GLD
modified microglial responses to psychosine. These data offer a novel perspective and
enhance understanding of the microglial contribution to GLD pathogenesis.